| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $95M | ||
| $91M |
Buys | $1,137,688 | 6 | 100 |
Sells | $0 | 0 | 0 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | 2 | $578,338 | 0 | $0 | $578,338 |
| Kurzius Lawrence Erik | director | 1 | $213,000 | 0 | $0 | $213,000 |
| Modi Rajeev A. | SEE REMARKS | 2 | $195,924 | 0 | $0 | $195,924 |
| VanHimbergen Robert M | EVP and CFO | 1 | $150,427 | 0 | $0 | $150,427 |
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Over the last 12 months, insiders at Elanco Animal Health Incorporated have bought $1.14M and sold $0 worth of Elanco Animal Health Incorporated stock.
On average, over the past 5 years, insiders at Elanco Animal Health Incorporated have bought $1.99M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Simmons Jeffrey N (PRESIDENT, CEO AND DIRECTOR) — $578,338. Kurzius Lawrence Erik (director) — $213,000. Modi Rajeev A. (SEE REMARKS) — $195,924.
The last purchase of 4,971 shares for transaction amount of $99,843 was made by Simmons Jeffrey N (PRESIDENT, CEO AND DIRECTOR) on 2026‑05‑15.
| 2026-05-15 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | 4,971 0.001% | $20.09 | $99,843 | +16.72% | ||
| 2026-05-15 | Modi Rajeev A. | SEE REMARKS | 4,911 0.001% | $20.35 | $99,939 | +16.72% | ||
| 2025-12-12 | Kurzius Lawrence Erik | director | 10,000 0.002% | $21.30 | $213,000 | +11.18% | ||
| 2025-12-11 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | 22,000 0.0045% | $21.75 | $478,496 | +11.24% | ||
| 2025-12-11 | VanHimbergen Robert M | EVP and CFO | 6,950 0.0014% | $21.64 | $150,427 | +11.24% | ||
| 2025-12-11 | Modi Rajeev A. | SEE REMARKS | 4,500 0.0009% | $21.33 | $95,985 | +11.24% | ||
| 2025-03-11 | Kurzius Lawrence Erik | director | 10,000 0.0021% | $10.20 | $102,000 | +84.56% | ||
| 2025-03-07 | Kurzius Lawrence Erik | director | 10,000 0.002% | $10.90 | $109,000 | +65.53% | ||
| 2025-03-05 | HOOVER R DAVID | director | 25,000 0.005% | $10.90 | $272,558 | +69.86% | ||
| 2024-08-22 | Harrington Michael J | director | 3,500 0.0007% | $14.85 | $51,974 | -11.91% | ||
| 2024-08-12 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | 100,000 0.02% | $13.01 | $1.3M | -1.68% | ||
| 2024-05-21 | DOYLE WILLIAM F | director | 15,000 0.0031% | $16.98 | $254,700 | -23.41% | ||
| 2024-03-08 | Harrington Michael J | director | 3,100 0.0006% | $16.29 | $50,494 | -17.75% | ||
| 2024-03-08 | DOYLE WILLIAM F | director | 15,000 0.003% | $16.30 | $244,500 | -17.75% | ||
| 2024-03-06 | HOOVER R DAVID | director | 20,000 0.0041% | $16.14 | $322,808 | -15.48% | ||
| 2023-03-14 | HOOVER R DAVID | director | 5,000 0.001% | $9.55 | $47,750 | +22.66% | ||
| 2023-03-13 | HOOVER R DAVID | director | 5,000 0.001% | $9.46 | $47,288 | +23.84% | ||
| 2023-03-10 | Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | 15,000 0.0031% | $9.60 | $143,972 | +19.49% | ||
| 2023-03-03 | HOOVER R DAVID | director | 10,000 0.002% | $11.13 | $111,300 | +1.49% | ||
| 2022-11-11 | BILBREY JOHN P | director | 7,500 0.0015% | $13.24 | $99,267 | -16.77% |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR | 171971 0.0344% | $4.06M | 9 | 0 | <0.0001% |
| Modi Rajeev A. | SEE REMARKS | 160812 0.0322% | $3.8M | 3 | 0 | <0.0001% |
| Kurzius Lawrence Erik | director | 131773 0.0264% | $3.11M | 4 | 0 | +47.4% |
| VanHimbergen Robert M | EVP and CFO | 124233 0.0249% | $2.94M | 1 | 0 | |
| BAYER AKTIENGESELLSCHAFT | 10 percent owner | 18446429 3.6934% | $435.89M | 0 | 1 | |
| HOOVER R DAVID | director | 210000 0.042% | $4.96M | 24 | 0 | <0.0001% |
| Harrington Michael J | director | 81094 0.0162% | $1.92M | 6 | 0 | <0.0001% |
| DOYLE WILLIAM F | director | 76330 0.0153% | $1.8M | 2 | 0 | <0.0001% |
| BILBREY JOHN P | director | 41722 0.0084% | $985,890.86 | 6 | 0 | <0.0001% |
| Hicks Michael-Bryant | See Remarks | 33936 0.0068% | $801,907.68 | 2 | 0 | <0.0001% |
| Anand Kapila K | director | 27467 0.0055% | $649,045.21 | 3 | 0 | <0.0001% |
| Kinard David S | See Remarks | 22569 0.0045% | $533,305.47 | 2 | 0 | <0.0001% |
| LIN SARENA S | See Remarks | 20000 0.004% | $472,600.00 | 1 | 0 | <0.0001% |
| Herendeen Paul | 17307 0.0035% | $408,964.41 | 1 | 0 | <0.0001% | |
| GARCIA ART A | director | 16465 0.0033% | $389,067.95 | 2 | 0 | +12.26% |
| Schacht Aaron L | See Remarks | 13924 0.0028% | $329,024.12 | 2 | 0 | <0.0001% |
| Cabral Ramiro Martin | See Remarks | 12741 0.0026% | $301,069.83 | 2 | 0 | <0.0001% |
| YOUNG TODD S. | See Remarks | 5000 0.001% | $118,150.00 | 2 | 0 | +15.95% |
| Kochevar Deborah Turner | director | 3783 0.0008% | $89,392.29 | 1 | 0 | <0.0001% |
| Urbanek David Alan | See Remarks | 76 0% | $1,795.88 | 3 | 0 | <0.0001% |
| Meer James M | Chief Accounting Officer | 225 0% | $5,316.75 | 1 | 0 | <0.0001% |
$910,099,463 | 123 | 11.52% | $2.01B | |
Elanco Animal Health Incorporated (ELAN) | $25,613,591 | 65 | -3.30% | $11.8B |
$218,350,131 | 64 | 16.68% | $650.75M | |
$14,599,168 | 59 | 12.79% | $1.84B | |
$102,709,455 | 46 | 30.55% | $894.87M | |
$11,542,910 | 40 | 56.19% | $1.24B | |
$73,406,903 | 39 | -5.33% | $1.5B | |
$21,020,549 | 38 | -2.84% | $16.48B | |
$12,998,723 | 30 | 3.46% | $4.39B | |
$6,506,230 | 27 | -16.20% | $1.02B | |
$78,335,024 | 20 | 4.77% | $33.3B | |
$83,406,412 | 19 | 21.96% | $2.6B | |
$2,769,748 | 17 | -1.91% | $18.49B | |
$1,843,996 | 10 | 22.92% | $870.39M | |
$1,718,514 | 9 | 38.13% | $590.84M | |
$26,633,903 | 9 | 42.23% | $1.08B | |
$141,200 | 8 | 41.74% | $6.57B | |
$725,133 | 7 | 30.62% | $1.31B | |
$32,954,224 | 5 | -0.22% | $39.81B |
| Increased Positions | 278 | +62.9% | 32M | +5.59% |
| Decreased Positions | 191 | -43.21% | 64M | -11.28% |
| New Positions | 119 | New | 9M | New |
| Sold Out Positions | 42 | Sold Out | 8M | Sold Out |
| Total Postitions | 529 | +19.68% | 539M | -5.69% |
| Dodge & Cox | $1.86M | 16.65% | 82.76M | -135,395 | -0.16% | 2025-09-30 |
| Fmr Llc | $1.47M | 13.15% | 65.36M | +473,983 | +0.73% | 2025-09-30 |
| Primecap Management Co/Ca/ | $1.13M | 10.05% | 49.96M | -2M | -3.49% | 2025-09-30 |
| Vanguard Group Inc | $1.09M | 9.78% | 48.59M | +759,623 | +1.59% | 2025-09-30 |
| Blackrock, Inc. | $1.04M | 9.29% | 46.18M | +23M | +100.15% | 2025-09-30 |
| T. Rowe Price Investment Management, Inc. | $709,606.00 | 6.34% | 31.51M | +12M | +61.14% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $556,439.00 | 4.97% | 24.71M | +2M | +8.63% | 2025-09-30 |
| Ubs Group Ag | $370,863.00 | 3.31% | 16.47M | +6M | +56.74% | 2025-09-30 |
| State Street Corp | $343,335.00 | 3.07% | 15.25M | +6M | +67.04% | 2025-09-30 |
| Black Creek Investment Management Inc. | $281,105.00 | 2.51% | 12.48M | -7M | -35.16% | 2025-09-30 |